NO20060109L - Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning - Google Patents

Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning

Info

Publication number
NO20060109L
NO20060109L NO20060109A NO20060109A NO20060109L NO 20060109 L NO20060109 L NO 20060109L NO 20060109 A NO20060109 A NO 20060109A NO 20060109 A NO20060109 A NO 20060109A NO 20060109 L NO20060109 L NO 20060109L
Authority
NO
Norway
Prior art keywords
a1at
alpha
preparation
detergents
antitrypsin solution
Prior art date
Application number
NO20060109A
Other languages
English (en)
Norwegian (no)
Inventor
Juergen Romisch
Petra Schulz
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of NO20060109L publication Critical patent/NO20060109L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20060109A 2003-08-12 2006-01-06 Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning NO20060109L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49409703P 2003-08-12 2003-08-12
PCT/EP2004/009043 WO2005014648A1 (en) 2003-08-12 2004-08-12 Process for preparing an alpha-1-antitrypsin solution

Publications (1)

Publication Number Publication Date
NO20060109L true NO20060109L (no) 2006-02-15

Family

ID=34135316

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060109A NO20060109L (no) 2003-08-12 2006-01-06 Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning

Country Status (22)

Country Link
US (1) US20060194300A1 (enExample)
EP (1) EP1654284B1 (enExample)
JP (1) JP4668904B2 (enExample)
KR (1) KR20060070543A (enExample)
CN (1) CN1867582B (enExample)
AT (1) ATE428730T1 (enExample)
AU (1) AU2004262578B2 (enExample)
BR (1) BRPI0412835A (enExample)
CA (1) CA2534900A1 (enExample)
DE (1) DE602004020632D1 (enExample)
DK (1) DK1654284T3 (enExample)
ES (1) ES2324168T3 (enExample)
IL (1) IL172868A0 (enExample)
NO (1) NO20060109L (enExample)
PL (1) PL1654284T3 (enExample)
PT (1) PT1654284E (enExample)
RS (1) RS20060077A (enExample)
RU (1) RU2370500C2 (enExample)
SI (1) SI1654284T1 (enExample)
UA (1) UA86775C2 (enExample)
WO (1) WO2005014648A1 (enExample)
ZA (1) ZA200601206B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1664123E (pt) * 2003-09-22 2008-07-16 Kamada Ltd Preparação em larga escala de um inibidor da alfa-1 proteinase e sua utilização
ES2246694B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Nanoparticulas pegiladas.
ES2246695B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
CN100354301C (zh) * 2005-10-13 2007-12-12 南京工业大学 化学合成多肽的新型大规模分离制备技术
CN100562523C (zh) * 2006-07-26 2009-11-25 河北大安制药有限公司 α1-抗胰蛋白酶的制备方法
ES2611944T3 (es) * 2007-11-02 2017-05-11 Grifols Therapeutics Inc. Procedimiento, composición y artículo de fabricación para proporcionar alfa-1-antitripsina
CN102127165B (zh) * 2010-01-15 2013-09-04 上海莱士血液制品股份有限公司 一种从血浆组分四沉淀中制备高纯ApoA-I的生产工艺
CN102731642B (zh) * 2011-04-14 2014-01-29 上海莱士血液制品股份有限公司 从人血浆组分四沉淀制备高纯Apoa-I的生产工艺
US9353165B2 (en) * 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
AU2013205138B2 (en) 2012-08-09 2015-06-25 Grifols, S.A. Caprylate Viral Deactivation
EP3313859B1 (en) 2015-06-26 2019-11-20 Ferring BV Methods of purification and/or viral inactivation
AU2017214678B2 (en) * 2016-02-03 2024-02-01 Plasma Technologies, Llc Methods for extracting proteins from a blood-based material
AU2018357917B2 (en) 2017-10-30 2024-08-01 Takeda Pharmaceutical Company Limited Environmentally compatible detergents for inactivation of lipid-enveloped viruses
CN111991571B (zh) * 2020-08-12 2022-04-05 湖州师范学院 一种柱上低pH病毒灭活的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS584728A (ja) * 1981-05-01 1983-01-11 メデイカル・リサ−チ・インステイチユ−ト・オブ・サンフランシスコ・コ−ポレ−シヨン α−１−抗トリプシンの精製
US4379087A (en) * 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
ES2053606T3 (es) * 1987-04-27 1994-08-01 Miles Inc Metodo de preparacion de un inhibidor de alfa-1-proteinasa de alta pureza.
KR920005689B1 (ko) * 1989-12-21 1992-07-13 국제약품공업주식회사 혈청으로부터 알파-1-안티트립신의 분리 정제 및 혈중 알파-1-안티트립신 양의 검정키트
DE4125625C2 (de) * 1991-08-02 1999-12-02 Octapharma Ag Glarus Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
SE9301582D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Purification of plasma proteins
DE4407837C1 (de) * 1994-03-09 1995-08-17 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
EP1736483A3 (en) * 1995-09-07 2008-07-30 Pharming Intellectual Property BV Purification of alpha-1 proteinase inhibitor
JP4105249B2 (ja) * 1996-08-09 2008-06-25 財団法人化学及血清療法研究所 α２プラスミンインヒビターの製造方法
AT407114B (de) * 1997-06-10 2000-12-27 Immuno Ag Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
AU2004262578A1 (en) 2005-02-17
US20060194300A1 (en) 2006-08-31
JP2007523883A (ja) 2007-08-23
DE602004020632D1 (de) 2009-05-28
KR20060070543A (ko) 2006-06-23
BRPI0412835A (pt) 2006-09-26
CA2534900A1 (en) 2005-02-17
DK1654284T3 (da) 2009-07-20
WO2005014648A1 (en) 2005-02-17
UA86775C2 (ru) 2009-05-25
IL172868A0 (en) 2006-06-11
PT1654284E (pt) 2009-07-06
ATE428730T1 (de) 2009-05-15
CN1867582A (zh) 2006-11-22
EP1654284A1 (en) 2006-05-10
RS20060077A (sr) 2008-08-07
AU2004262578B2 (en) 2010-05-06
ZA200601206B (en) 2007-05-30
RU2006107533A (ru) 2006-07-27
SI1654284T1 (sl) 2009-10-31
JP4668904B2 (ja) 2011-04-13
CN1867582B (zh) 2010-06-16
ES2324168T3 (es) 2009-07-31
EP1654284B1 (en) 2009-04-15
RU2370500C2 (ru) 2009-10-20
PL1654284T3 (pl) 2009-09-30

Similar Documents

Publication Publication Date Title
NO20060109L (no) Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning
RU95108231A (ru) Glp-1-молекулярный комплекс, фармацевтическая композиция и способ получения комплекса
YU23599A (sh) Stabilizovani antihistaminski sirup
EA200201012A1 (ru) Способы стерилизации биологических материалов
WO2002096457A3 (en) Stable liquid formulations of antibodies
BR0115730A (pt) materiais antimicrobianos foto-estabilizados
NZ593214A (en) Compounds and Processes for preparing serine protease inhibitors
EA200970726A1 (ru) Твердый препарат, содержащий алоглиптин и пиоглитазон
GEP20012580B (en) Substituted 4-Hydroxy-Phenylalcanoic Acid Derivatives With Agonist Activity to PPAR-Gamma, Methods for Their Production, Pharmaceutical Conposition and Methods for Treatment
RU94045798A (ru) Стереоизомеры итраконазола или саперконазола, способ их получения, их комплексы и способ получения, фармацевтическая композиция на их основе и ее получение, способ получения водных растворов с повышенной концентрацией итраконазола или саперконазола
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
NO20006606L (no) Fremgangsmåte for fremstilling av en vandig monoester peroksykarboksylsyreopplösning, opplösningen som kan oppnås ved denne fremgangsmåten og dens anvendelse som desinfeksjonsmiddel
WO2004037784A3 (en) Pyrrolidones with anti-hiv activity
EP0276375A3 (en) Process for the preparation of optically active alpha-hydroxynitriles
ATE208765T1 (de) 2-amino-benzoxazinone zur behandlung von viralen infektionen
FR2866890B1 (fr) Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
AR035808A1 (es) Proceso de deshidratacion capaz de minimizar la epimerizacion de un grupo hidroxilo por ciertas equinocandinas
EP1831239B8 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process
WO2004037853A3 (en) Quinolones with anti-hiv activity
BRPI0407448A (pt) Processo quìmico
IT1265964B1 (it) Micro-granuli ottenuti tramite estrusione-sferonizzazione contenenti una ciclodestrina.
BRPI0414580A (pt) derivado do ácido fenilacético, processos para sua produção e uso
ATE503760T1 (de) Behandlung hochleistungsfähiger pigmentfarbstoffe mit dispergierenden etheramin-salzen
JPH07113024B2 (ja) ピロロキノリンキノンの精製方法
Izumi et al. Incorporation of the sulfur of L-[35S] methionine into the biotin molecule by intact cells of Rhodotorula glutinis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application